Blood transfusions and steatohepatitis are independent risk factors for complications following liver resection for colorectal cancer liver metastases.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28855987)

Published in Mol Clin Oncol on August 01, 2017

Authors

Marco Massani1, Giovanni Capovilla2, Cesare Ruffolo1, Roberta Bonariol1, Paola Maccatrozzo1, Francesco Tuci1, Giuseppe Battistella3, Gian Luca Grazi4, Nicolò Bassi1,2

Author Affiliations

1: Department of Surgery, Regional Center for HPB Surgery, Regional Hospital of Treviso, I-31100 Treviso, Italy.
2: Department of Surgical, Oncological and Gastroenterological Sciences, Padova University Hospital, University of Padova, I-35128 Padova, Italy.
3: Department of Statistics and Epidemiology, Azienda ULSS 9, I-31100 Treviso, Italy.
4: Department of Surgery, Regina Elena National Cancer Institute, I-00144 Rome, Italy.

Articles cited by this

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg (2004) 55.13

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care (2004) 30.40

Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (2005) 29.57

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med (2004) 18.93

Steatohepatitis: a tale of two "hits"? Gastroenterology (1998) 13.21

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet (2008) 9.92

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol (2006) 5.78

Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol (2007) 4.95

Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol (2004) 4.78

Medical hazards of obesity. Ann Intern Med (1993) 3.93

The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg (2005) 3.46

Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg (2003) 3.14

Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg (2006) 3.05

Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg (2005) 3.04

The Brisbane 2000 terminology of liver anatomy and resections. HPB 2000; 2:333-39. HPB (Oxford) (2002) 2.68

Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol (2005) 2.38

CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR. Eur J Cancer (1999) 2.24

Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg (2008) 2.10

Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg (2003) 2.05

Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg (1999) 1.94

Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol (2005) 1.92

Bile leakage and liver resection: Where is the risk? Arch Surg (2006) 1.71

Immunologic abnormalities in patients receiving multiple blood transfusions. Ann Intern Med (1984) 1.66

Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. J Am Coll Surg (2007) 1.52

Steatosis as a risk factor in liver surgery. Ann Surg (2007) 1.48

Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg (2007) 1.46

Impact of obesity on postoperative outcome of hepatic resection for colorectal metastases. Surgery (2015) 1.39

Nonalcoholic fatty liver disease. Prog Liver Dis (1986) 1.11

Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases. Surgery (2009) 1.10

Influence of body mass index on complications and oncologic outcomes following hepatectomy for malignancy. J Gastrointest Surg (2010) 1.01

Blood transfusion impairs the healing of experimental intestinal anastomoses. Ann Surg (1992) 0.98

Safety of liver resections in obese and overweight patients. World J Surg (2010) 0.96

Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience. J Am Coll Surg (2012) 0.96

Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database. J Clin Oncol (2015) 0.93

Liver resection in obese patients: results of a case-control study. HPB (Oxford) (2010) 0.87

Chemotherapy-associated liver injury and its influence on outcome after resection of colorectal liver metastases. Surgery (2013) 0.86

Adverse effect of perioperative blood transfusions on survival after hepatic resection for hepatocellular carcinoma. Hepatogastroenterology (1997) 0.85

Obesity rather than neoadjuvant chemotherapy predicts steatohepatitis in patients with colorectal metastasis. Am J Surg (2013) 0.80